what are the Recommendations for Other Drug Treatment
Referenced studies that support the recommendations are summa-
rized in the Online Data Supplements.?
In patients with HF who experience hyperkale- mia (serum potassium level ?5.5 mEq/L) while taking a renin-angiotensin-aldosterone system inhibitor (RAASi), the effectiveness of potas- sium binders (patiromer, sodium zirconium cyclosilicate) to improve outcomes by facilitat- ing continuation of RAASi therapy is uncer- tain.